Provisional Consent to the Distribution of a New Medicine Pursuant to section 23 of the Medicines Act 1981, the Minister of Health hereby provisionally consents to the sale, supply or use in New Zealand of the new medicine set out in the Schedule hereto: Schedule Product: Xeloda. Active Ingredient(s): Capecitabine 150 mg. Dosage Form: Film coated tablet. NZ Sponsor: Roche Products (New Zealand) Limited. Manufacturer(s): Hoffmann-La Roche Inc, Nutley, New Jersey, United States of America. Product: Xeloda. Active Ingredient(s): Capecitabine 500 mg. Dosage Form: Film coated tablet. NZ Sponsor: Roche Products (New Zealand) Limited. Manufacturer(s): Hoffmann-La Roche Inc, Nutley, New Jersey, United States of America. Note: This consent is valid for 2 years from the date of publication of this notice. Dated this 29th day of July 1999. G. R. BOYD, Chief Advisor, Safety and Regulation (pursuant to delegation given by the Minister of Health on the 20th day of February 1997).